🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A safety extension study to evaluate the long-term safety of QGE031 240 mg ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-05-24
Trial ID
NCT02649218
Treatments Being Tested
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
This study planned to assess long-term safety of QGE031 during 12 months tr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-03-27
Trial ID
NCT02075008
Treatments Being Tested
This is a placebo and active-controlled phase 2b dose-finding study to eval...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-07-15
Trial ID
NCT02477332
Treatments Being Tested
This was an extension study to evaluate the long-term safety and efficacy o...
Status
Terminated
Location
Allervie Clinical Research
Start Date
2023-04-27
Trial ID
NCT05678959
Treatments Being Tested
This study assessed the effect on asthma control of different dose levels a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01716754
Treatments Being Tested
This was a 52-week, Phase 3 multi-center, randomized, double-blind and plac...
Status
Terminated
Location
Allervie Clinical Research
Start Date
2021-12-07
Trial ID
NCT04984876
Treatments Being Tested
To evaluate the safety and efficacy of QGE031 versus placebo in patients wi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-01
Trial ID
NCT01688882